Navigation Links
Study paints complex health portrait of single-room occupancy hotel tenants in Downtown Eastside
Date:8/9/2013

A new study is revealing the multiple health concerns faced by an estimated 3,000 tenants in single-room occupancy (SRO) hotels in Vancouver's Downtown Eastside (DTES).

The results of the study aim to better inform the provision of health care and housing among an often-overlooked segment of the population.

Due to their affordability, SROs are often the only alternative to homelessness for low-income individuals in Vancouver and other major cities. Some SROs are substandard and many tenants suffer from substance dependence, mental illness and infectious diseases.

The study, published today in the American Journal of Psychiatry, shows that two-thirds of SRO tenants surveyed were previously homeless and suffered from an average of three illnesses at the same time.

Ninety-five per cent had substance dependence and almost two-thirds were involved in injection drug use. Nearly half of the participants suffered from psychosis, and nearly half had a neurological disorder. Eighteen per cent of the residents surveyed were HIV-positive and 70 per cent had been exposed to Hepatitis C.

"Even with the great progress that has been made in decreasing overdose deaths through the establishment of InSite, the supervised injection site, the death rate in our participants was still nearly five times greater than in the general population," says Dr. William Honer, Professor and Head of the UBC Department of Psychiatry and senior author of the study.

"Compared with homelessness, there has been relatively little research into the magnitude of the health problems experienced by people living in marginal housing," says Honer.


'/>"/>

Contact: Brian Lin
brian.lin@ubc.ca
604-822-2234
University of British Columbia
Source:Eurekalert

Page: 1

Related medicine news :

1. Study Suggests Vaccine May Help Kids With Brain Cancer
2. Study reveals how cancer drug causes diabetic-like state
3. Coffee Drinking in Pregnancy Wont Lead to Sleepless Baby: Study
4. Lower GI problems plague many with rheumatoid arthritis, Mayo Clinic study finds
5. Veggies Like Broccoli, Cabbage May Help Fight Breast Cancer: Study
6. No Added Cancer Risk From Hip Replacement Materials: Study
7. Reported Decline in U.S. Pneumonia Deaths May Be False: Study
8. Early Study Finds Some Promise for Lung Cancer Vaccine
9. Narcissists Often Ace Job Interviews, Study Finds
10. Sexual objectification of female artists in music videos exists regardless of race, MU study finds
11. Soy may alleviate hot flashes in menopause, large-scale study finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... 2017 , ... Resoundant, Inc., the developer of Magnetic ... annual customer education symposium, a world-class learning conference that offers educational content designed ... 31, 2017 at the Atlanta Marriott Marquis in Atlanta, Georgia. , Innovations for ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... of all holidays (IBT World Travel Trends Report). As travelers visit both urban ... range in temperatures, and prolonged sun exposure. In response, the outdoor industry has ...
(Date:3/28/2017)... ... ... Alert Sentry Group LLC., a leader in the Personal Emergency Response System industry, introduced ... Plus. These iSAFE products are the most affordable and most advanced medical alert systems ... direct GPS Location and two-way calling with the push of a button on a ...
(Date:3/28/2017)... ... , ... The Radiology Business Management Association (RBMA) is pleased to ... executive director. Mr. Still was selected through a careful months-long search by the RBMA ... known to our members, has been a part of building the RBMA since 1992,” ...
(Date:3/28/2017)... ... March 28, 2017 , ... Neurotechnology , a provider ... and attendance tracking products: the new NCheck Cloud Bio Attendance cloud-based service and ... biometric face recognition to enable users to check in and out from anywhere ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... TEL AVIV, Israel , March 28, 2017 ... . This new business entity, Emosis Ltd, headquartered in ... and development of novel assays complementing the mother company existing technology ... support commercialization and sales development of Emosis kits. ... This strategic move starts building Emosis ...
(Date:3/28/2017)... Mass. , March 28, 2017 ... company developing innovative therapeutics that address significant unmet ... a patent from the Japan Patent Office (JPO) ... connective tissue growth factor (CTGF) for the treatment ... limited to skin fibrosis and proliferative retinopathy (Japanese ...
(Date:3/28/2017)... Elysium Health joins major pharmaceutical companies to ... Cambridge academic scientists through ... Institute today announces Elysium Health as a partner to the ... collaborative projects with academic researchers in Cambridge ... major research investment outside the U.S. for the ...
Breaking Medicine Technology: